These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 22648570)
1. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer. Fornasa F; Nesoti MV; Bovo C; Bonavina MG J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570 [TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients. Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958 [TBL] [Abstract][Full Text] [Related]
3. Discrimination of axillary metastatic from nonmetastatic lymph nodes with PROPELLER diffusion-weighted MR imaging in a metastatic breast cancer model and its correlation with cellularity. Junping W; Tongguo S; Yunting Z; Chunshui Y; Renju B J Magn Reson Imaging; 2012 Sep; 36(3):624-31. PubMed ID: 22570219 [TBL] [Abstract][Full Text] [Related]
4. Detection of axillary node metastasis using diffusion-weighted MRI in breast cancer. Kamitani T; Hatakenaka M; Yabuuchi H; Matsuo Y; Fujita N; Jinnouchi M; Nagao M; Shirahane K; Tokunaga E; Honda H Clin Imaging; 2013; 37(1):56-61. PubMed ID: 23206608 [TBL] [Abstract][Full Text] [Related]
5. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer. Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236 [TBL] [Abstract][Full Text] [Related]
6. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging. Razek AA; Lattif MA; Denewer A; Farouk O; Nada N Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535 [TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of diffusion-weighted MRI with STIR-EPI in differential diagnosis of cervical lymph nodes]. Zhang Y; Liang BL; Gao L; Zhong JL; Ye RX; Shen J Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):70-3. PubMed ID: 17575700 [TBL] [Abstract][Full Text] [Related]
8. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Holzapfel K; Duetsch S; Fauser C; Eiber M; Rummeny EJ; Gaa J Eur J Radiol; 2009 Dec; 72(3):381-7. PubMed ID: 18995981 [TBL] [Abstract][Full Text] [Related]
9. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study. Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788 [TBL] [Abstract][Full Text] [Related]
10. Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer. Yamaguchi K; Schacht D; Nakazono T; Irie H; Abe H J Magn Reson Imaging; 2015 Sep; 42(3):771-8. PubMed ID: 25556886 [TBL] [Abstract][Full Text] [Related]
11. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Vandecaveye V; De Keyzer F; Vander Poorten V; Dirix P; Verbeken E; Nuyts S; Hermans R Radiology; 2009 Apr; 251(1):134-46. PubMed ID: 19251938 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability. Scaranelo AM; Eiada R; Jacks LM; Kulkarni SR; Crystal P Radiology; 2012 Feb; 262(2):425-34. PubMed ID: 22143924 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis value of 3.0 T diffusion-weighted imaging with background suppression magnetic resonance for metastatic lymph nodes in rectal cancer]. Zhuang XZ; Yu SP; Cui J; Chen CQ; Zhao XJ; Pan BT; Li ZP Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Nov; 14(11):842-5. PubMed ID: 22116716 [TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
15. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. Kim JK; Kim KA; Park BW; Kim N; Cho KS J Magn Reson Imaging; 2008 Sep; 28(3):714-9. PubMed ID: 18777531 [TBL] [Abstract][Full Text] [Related]
16. [Differentiation of axillary inflammatory and metastatic lymph nodes with diffusion-weighted imaging in animal modes]. Bai X; Liao Q; Wang JP; Bai RJ; Sun HR; Yu CS; Zhang YT Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(9):592-5. PubMed ID: 22800945 [TBL] [Abstract][Full Text] [Related]
17. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC). Xu L; Tian J; Liu Y; Li C J Magn Reson Imaging; 2014 Jul; 40(1):200-5. PubMed ID: 24923480 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body. Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745 [TBL] [Abstract][Full Text] [Related]
20. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. Nakayama J; Miyasaka K; Omatsu T; Onodera Y; Terae S; Matsuno Y; Cho Y; Hida Y; Kaga K; Shirato H J Comput Assist Tomogr; 2010 Jan; 34(1):1-8. PubMed ID: 20118713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]